Stuart Therapeutics Unveils Phase III Results for Novel Dry Eye Candidate
ST-100 missed its primary endpoint—but showed visible healing on the eye’s surface by Day 4. Stuart Therapeutics (Florida, United States)…
latest posts
ST-100 missed its primary endpoint—but showed visible healing on the eye’s surface by Day 4. Stuart Therapeutics (Florida, United States)…